Review Mortgage Lenders

Chevy Chase Fsb

Chevy Chase Fsb - News


Bay Bank Hires Two New Executives
http://online.wsj.com/article/PR-CO-20140107-908215.html
7, 2014 (GLOBE NEWSWIRE) -- Bay Bank, FSB announced today a strengthening of its executive management team with two new hires. The Bank has hired Larry Pickett as its new Chief Financial Officer and Russ McAtee as its new Chief Retail Banking Mr

Citigroup May Buy Chevy Chase Bank - Nov 14

Citigroup is in talks to buy Chevy Chase Bank FSB. Also, Gazprom eyes a 20% stake in Repsol.

AbbVie Inc (ABBV) Stake Lowered by First American Trust FSB

First American Trust FSB decreased its position in AbbVie Inc (NYSE:ABBV) by 5.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,521 shares of the company’s stock after selling 200 shares during the period. First American Trust FSB’s holdings in AbbVie were worth $230,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. Curbstone Financial Management Corp increased its stake in shares of AbbVie by 3.0% in the first quarter. Curbstone Financial Management Corp now owns 10,231 shares of the company’s stock worth $667,000 after buying an additional 295 shares in the last quarter. Chevy Chase Trust Holdings Inc. increased its stake in AbbVie by 0.8% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 1,495,012 shares of the company’s stock valued at $97,414,000 after buying an additional 11,789 shares during the period. Franklin Street Advisors Inc. NC increased its stake in AbbVie by 10.6% in the first quarter. Franklin Street Advisors Inc. NC now owns 191,279 shares of the company’s stock valued at $12,464,000 after buying an additional 18,301 shares during the period. Liberty Capital Management Inc. increased its stake in AbbVie by 5.9% in the first quarter. Liberty Capital Management Inc. now owns 29,886 shares of the company’s stock valued at $1,947,000 after buying an additional 1,655 shares during the period. Finally, Integrated Investment Consultants LLC increased its stake in AbbVie by 0.3% in the first quarter. Integrated Investment Consultants LLC now owns 12,778 shares of the company’s stock valued at $833,000 after buying an additional 44 shares during the period. 66.67% of the stock is currently owned by institutional investors and hedge funds.

First American Trust FSB Has $4.995 Million Stake in Pfizer Inc. (PFE)

First American Trust FSB reduced its stake in shares of Pfizer Inc. (NYSE:PFE) by 3.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 146,013 shares of the biopharmaceutical company’s stock after selling 5,262 shares during the period. Pfizer comprises 1.5% of First American Trust FSB’s investment portfolio, making the stock its 21st largest position. First American Trust FSB’s holdings in Pfizer were worth $4,995,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in PFE. Chevy Chase Trust Holdings Inc. boosted its position in Pfizer by 0.9% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 5,428,710 shares of the biopharmaceutical company’s stock valued at $185,715,000 after buying an additional 46,366 shares during the last quarter. Bridges Investment Management Inc. boosted its position in Pfizer by 10.3% in the first quarter. Bridges Investment Management Inc. now owns 53,793 shares of the biopharmaceutical company’s stock valued at $1,840,000 after buying an additional 5,026 shares during the last quarter. Cohen Lawrence B acquired a new position in Pfizer during the first quarter valued at approximately $201,000. Triangle Securities Wealth Management boosted its position in Pfizer by 8.4% in the first quarter. Triangle Securities Wealth Management now owns 16,764 shares of the biopharmaceutical company’s stock valued at $573,000 after buying an additional 1,299 shares during the last quarter. Finally, Atalanta Sosnoff Capital LLC boosted its position in Pfizer by 19.7% in the first quarter. Atalanta Sosnoff Capital LLC now owns 761,670 shares of the biopharmaceutical company’s stock valued at $26,057,000 after buying an additional 125,193 shares during the last quarter. Institutional investors own 69.53% of the company’s stock.